Alnylam Pharmaceuticals (ALNY) Capital Expenditures (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.26% |
| Dec 31, 2025 | -25.64% |
| Sep 30, 2025 | 740.70% |
| Jun 30, 2025 | -154.50% |
| Mar 31, 2025 | -1.36% |
| Dec 31, 2024 | -62.30% |
| Sep 30, 2024 | 2,145.80% |
| Jun 30, 2024 | -152.59% |
| Mar 31, 2024 | -85.36% |
| Dec 31, 2023 | -10.43% |
| Sep 30, 2023 | 7.37% |
| Jun 30, 2023 | 14.60% |
| Mar 31, 2023 | 130.72% |
| Dec 31, 2022 | -373.84% |
| Sep 30, 2022 | -35.50% |
| Jun 30, 2022 | 207.72% |
| Mar 31, 2022 | 120.34% |
| Dec 31, 2021 | -256.88% |
| Sep 30, 2021 | 23.31% |
| Jun 30, 2021 | 189.96% |
| Mar 31, 2021 | -66.36% |
| Dec 31, 2020 | 74.49% |
| Sep 30, 2020 | -25.45% |
| Jun 30, 2020 | -15.08% |
| Mar 31, 2020 | 122.69% |
| Dec 31, 2019 | -339.82% |
| Sep 30, 2019 | -31.00% |
| Jun 30, 2019 | 300.98% |
| Mar 31, 2019 | -87.84% |
| Dec 31, 2018 | 542.29% |
| Sep 30, 2018 | -206.68% |
| Jun 30, 2018 | 6.83% |
| Mar 31, 2018 | 2.55% |
| Dec 31, 2017 | -19.28% |
| Sep 30, 2017 | 18.60% |
| Jun 30, 2017 | -40.11% |
| Mar 31, 2017 | 413.68% |
| Dec 31, 2016 | -156.78% |
| Sep 30, 2016 | 32.47% |
| Jun 30, 2016 | 69.18% |
| Mar 31, 2016 | 192.26% |
| Dec 31, 2015 | -52.15% |
| Sep 30, 2015 | 412.42% |
| Jun 30, 2015 | -40.09% |
| Mar 31, 2015 | -40.16% |
| Dec 31, 2014 | 10.36% |
| Sep 30, 2014 | 72.52% |
| Jun 30, 2014 | 377.32% |
| Mar 31, 2014 | 113.08% |
| Dec 31, 2013 | -412.32% |
| Sep 30, 2013 | 150.66% |
| Jun 30, 2013 | -78.93% |
| Mar 31, 2013 | 128.92% |
| Dec 31, 2012 | -208.59% |
| Sep 30, 2012 | 243.05% |
| Jun 30, 2012 | 534.98% |
| Mar 31, 2012 | -49.81% |
| Dec 31, 2011 | 97.74% |
| Sep 30, 2011 | -44.09% |
| Jun 30, 2011 | 1,592.86% |
| Mar 31, 2011 | -97.54% |
| Dec 31, 2010 | 6.65% |
| Sep 30, 2010 | -25.38% |
| Jun 30, 2010 | 30.36% |
| Mar 31, 2010 | -13.28% |
| Dec 31, 2009 | 71.64% |